Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation

NCT04098393 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancies

Interventions

DRUG: Busulfan 3.2 mg/kg/day
DRUG: Fludarabine
DRUG: Melphalan
DRUG: Antithymocyte globulin (ATG)
DRUG: Busulfan 0.8 mg/kg
PROCEDURE: Allogeneic hematopoietic cell transplantation (Allo-HCT)

Sponsor

Memorial Sloan Kettering Cancer Center